Rudy Foddis
Overview
Explore the profile of Rudy Foddis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
652
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Marino R, Bertocci N, Bernabei M, Bonotti A, Mignani A, Fallahi P, et al.
Med Lav
. 2020 Oct;
111(5):399-403.
PMID: 33124611
Background: Every year in Italy and all around the world, cardiac arrest hits almost 1 person every 1000 people; a great deal of these events is likely to strike people...
22.
Antonelli A, Elia G, Ferrari S, Foddis R, De Marco S, Cristaudo A, et al.
Curr Genomics
. 2020 Oct;
21(3):157.
PMID: 33071609
No abstract available.
23.
Silvestri R, Pucci P, de Santi C, DellAnno I, Miglietta S, Corrado A, et al.
Front Genet
. 2020 Oct;
11:975.
PMID: 33014022
Soluble mesothelin-related peptide (SMRP) is a promising biomarker for malignant pleural mesothelioma (MPM), but several confounding factors can reduce SMRP-based test's accuracy. The identification of these confounders could improve the...
24.
Primary cell cultures for the personalized therapy in aggressive thyroid cancer of follicular origin
Fallahi P, Ferrari S, Elia G, Ragusa F, Patrizio A, Paparo S, et al.
Semin Cancer Biol
. 2020 Jun;
79:203-216.
PMID: 32569821
Thyroid cancer (TC) is the most prevalent endocrine malignancy. More than 90 % of TC is represented by differentiated TC (DTC) arising from the follicular thyroid cells. DTC includes papillary...
25.
Lacerenza S, Ciregia F, Giusti L, Bonotti A, Greco V, Giannaccini G, et al.
Cancer Genomics Proteomics
. 2020 Apr;
17(3):225-236.
PMID: 32345664
Background: Malignant pleural mesothelioma (MPM) a rare neoplasm linked to asbestos exposure is characterized by a poor prognosis. Soluble mesothelin is currently considered the most specific diagnostic biomarker. The aim...
26.
Gemignani F, Romei C, Ciampi R, Corrado A, Melaiu O, Figlioli G, et al.
Thyroid
. 2020 Apr;
30(11):1579-1588.
PMID: 32228166
Sporadic medullary thyroid carcinoma (sMTC) is an uncommon neoplasia arising from the calcitonin-producing parafollicular cells of the thyroid. Previous studies evaluated whether single nucleotide polymorphisms (SNPs) within (a pivotal proto-oncogene...
27.
Antonelli A, Ferrari S, Ragusa F, Elia G, Paparo S, Ruffilli I, et al.
Best Pract Res Clin Endocrinol Metab
. 2020 Feb;
34(1):101387.
PMID: 32107168
Graves' disease (GD) is the most common cause of hyperthyroidism in developed Countries. It is more common between 30 and 60 years; 5-10 times more frequent in women. The genetic...
28.
Corti A, Bonetti J, Dominici S, Piaggi S, Fierabracci V, Foddis R, et al.
Toxicol Sci
. 2019 Aug;
177(2):476-482.
PMID: 31388672
Asbestos is the main causative agent of malignant pleural mesothelioma. The variety known as crocidolite (blue asbestos) owns the highest pathogenic potential, due to the dimensions of its fibers as...
29.
Foddis R, Ficini G, Cristaudo A, Pistelli A, Carducci A, Caponi E, et al.
G Ital Med Lav Ergon
. 2018 Jun;
39(3):214-217.
PMID: 29916592
Objectives: A thorough and fully application of the principles of gender mainstreaming, in accordance with the European Community guidelines, to the health and safety at work, implies the systematic review...
30.
Scapellato M, Basso A, Bonfiglioli R, Foddis R, Larese Filon F, Simonini S, et al.
G Ital Med Lav Ergon
. 2018 Jun;
39(3):203-210.
PMID: 29916590
Objectives: A literature review was performed to highlight which work-related diseases express sex/gender differences in health outcomes and focus the main limits of studies in this field. Methods: The research,...